A parade of actors are expected to take the stand and testify against Craig McLachlan at a trial that kicked off Monday in his defamation case against Rocky Horror Show co-star Christie Whelan Browne and publishers ABC and Fairfax.
A class action over the failure of six managed investment schemes for eucalyptus wood in Tasmania has accused KPMG of failing to advise forestry giant Gunns that it had to tell growers about $720 million in financing it sought in 2007.
Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.
Catalyst Training is suing the Box Hill Institute and Centre for Adult Education over a botched subcontracting agreement, which it says the vocational education provider failed to seek government approval for.
Google has fought off a legal challenge to a decision rejecting a South Australian doctor’s bid to access search data and internal company documents in her second defamation claim against the tech giant over alleged defamatory material in search results.
Founder and former CEO of listed investment firm DomaCom is suing Nine over an episode of A Current Affair that allegedly suggested he was involved in a sham acquisition of agriculture company Austagri to boost his company’s share price.
Australia’s largest milk producer Van Dairy has hit Fonterra Australia with lawsuits alleging the processor misled farmers and engaged in unconscionable conduct when it slashed milk prices in 2016.
A NSW developer says law firm Sparke Helmore should face a heftier damages bill for its negligence in failing to alert it to an imminent deadline in two land sale contracts worth a combined $1.5 million that were part of a troubled $30 million development.
AGL Energy has defeated a green investor’s challenge to its demerger scheme booklet ahead of a vote on the controversial proposal, but has been ordered to rectify a video to disclose the climate-related risks of the plan.
Discount pharmacy Priceline cannot trade mark the signature bright pink that adorns it shopfront signs and awnings, an IP Australia delegate has found.